Anika Therapeutics, Inc.
ANIK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000898437
In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Anika Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −4 vs. Q1 2025
- Shares held
- 12.7M
- +7.33K (+0.1%) vs. Q1 2025
- Total value
- $134.2M
- −$56.5M (−29.6%) vs. Q1 2025
- New holders
- 16
- 39 more added
- Sold out
- 20
- 34 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 133 | $179.0M |
| Q1 2026 | 130 | $179.1M |
| Q4 2025 | 126 | $117.5M |
| Q3 2025 | 117 | $115.0M |
| Q2 2025 | 104 | $134.2M |
| Q1 2025 | 108 | $190.7M |
| Q4 2024 | 109 | $206.2M |
| Q3 2024 | 122 | $323.5M |
| Q2 2024 | 114 | $335.3M |
| Q1 2024 | 120 | $340.4M |
| Q4 2023 | 117 | $300.2M |
| Q3 2023 | 117 | $242.3M |
| Q2 2023 | 117 | $340.4M |
| Q1 2023 | 121 | $375.6M |
| Q4 2022 | 125 | $388.0M |
| Q3 2022 | 123 | $320.5M |
| Q2 2022 | 126 | $302.2M |
| Q1 2022 | 119 | $341.4M |
| Q4 2021 | 127 | $483.3M |
| Q3 2021 | 131 | $559.5M |
| Q2 2021 | 139 | $568.9M |
| Q1 2021 | 146 | $543.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 779,473 | $8.25M | 0.00% | +2,068+0.3% | Added |
| Caligan Partners LP | 1,435,130 | $15.2M | 2.95% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,528,286 | $16.2M | 0.00% | +9,025+0.6% | Added |
| Trigran Investments, Inc. | 2,036,511 | $21.5M | 3.74% | −5,342−0.3% | Reduced |
| Meros Investment Management, LP | 0 | $0 | 0.00% | −173,489−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −39,352−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −27,484−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −26,802−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −20,971−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −17,028−100.0% | Sold out |
| Connors Investor Services Inc | 0 | $0 | 0.00% | −14,403−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,628−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,753−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −8,516−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −6,351−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,927−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,607−100.0% | Sold out |
| Eastern Bank | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −575−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −426−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |